Fladgate advises WideCells on its £2m placing and publication of related prospectus


Our team: Paul Airley


Fladgate has advised Main Market listed WideCells Group Plc on its £2m placing and the publication of a related prospectus.  The financing will be used to provide working capital for the group and for the expansion and development of the WideCells, CellPlan and Wideacademy brands and products.

WideCells is a healthcare services company focused on providing stem cell services and insurance for stem cell treatments.

The Fladgate team was led by capital markets partner Paul Airley, assisted by corporate associate Victoria Miller.

Would you like to hear more?


View by date:


View by author: